At Miami Cancer Institute, every lung cancer patient receives molecular analysis to better understand the cancer subtype and help identify the best treatment plan using immunotherapy and other advanced therapies. We believe this is a critical step, as every lung cancer case is different, and modern treatment methods depend on careful and accurate analysis.
Miami Cancer Institute can provide access to clinical trials not widely available elsewhere. Clinical trials find new ways to treat and diagnose cancer and are ongoing. If an appropriate trial is available, we will talk to you about the benefits and risks.
At Miami Cancer Institute, we understand that the true definition of compassionate care is that nothing is more important than the patient sitting in front of you. We are ready to care for you.
The Association for Accreditation of Human Research Protection Programs has recognized Miami Cancer Institute for promoting ethically sound and safe human subject research practices.
Miami Cancer Institute has been awarded full accreditation by the Association for Accreditation of Human Research Protection Programs (AAHRPP), after having completed the accreditation process with zero deficiencies. This is a significant achievement and a testament to our commitment to the highest standards in promoting ethically sound and safe human subject research practices.
We’re Florida's only member of the Memorial Sloan Kettering Cancer Alliance. That means our physicians collaborate with national cancer care leaders to give patients the best cancer care, right here at home. We also share knowledge to improve cancer care now and for future generations.
Neil Nagovski, M.D., FACP, is a board-certified hematologist-oncologist at Baptist Health Miami Cancer Institute. He specializes in the treatment of malignant hematologic disorders, such as leukemias, lymphomas, plasma cell neoplasms, myeloproliferative disorders and bone marrow failure syndromes, as well as benign hematologic disorders.
Prior to joining Baptist Health, Dr. Nagovski was a hematologist-oncologist at Holy Cross Health – Michael & Dianne Bienes Comprehensive Cancer Center in Fort Lauderdale, Fla.
Dr. Nagovski earned his medical degree at First Tashkent State Medical Institute in Tashkent, Uzbekistan. He completed an internal medicine internship and residency at St. Barnabas Hospital, Weill Cornell Medicine, Cornell University in Bronx, N.Y. His post-doctoral training also includes a hematology-oncology fellowship at Strong Memorial Hospital of the University of Rochester, Wilmot Cancer Institute.
Dr. Nagovski is a fellow of the American College of Physicians and member of numerous professional organizations. He has participated in research on hematologic malignancies and lectured at national medical conferences. For five years, he served as a member of the Leukemia & Lymphoma Society Board of Trustees, Southern Florida Chapter.
Dr. Nagovski strives to make a difference in the community and in the lives of his patients and families. He finds it extremely rewarding to build relationships with his patients and their loved ones and be part of their journey toward healing and survivorship.
Dr. Nagovski is fluent in English and Russian. When he is not treating patients, he enjoys spending time with his family and traveling.
Baptist Health Cancer Care was ranked among the top 10 percent in the Country, and Baptist Health Miami Cancer Institute was ranked #1 in South Florida, with High Performing ratings in complex cancer care, prostate cancer surgery, lung cancer surgery and treating patients with leukemia, lymphoma & myeloma cancers. The Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital and Miami Cancer Institute both received High Performing ratings in colon cancer surgery.
I want to see the site in English
Continue In EnglishQuiero ver el sitio en Español
Continuar en español